Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Tetragon Partners GP Ltd
Form 13F · Q2 2026

Tetragon Partners GP Ltd

CIK 1515070Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$635M
Reported book value
43
Positions
12
Quarters on record
Top 50
Positions

Tetragon Partners GP Ltd — holdings

Top 32 positions of 43, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PATH Uipath Inc30.9M+22.8%$336M53.0%
2KGEI Kolibri Global Energy Inc6.8M+0.0%$34M5.3%
3AUTL Autolus Therapeutics Ltd9.5M+0.0%$15M2.4%
4LYFT Lyft Inc1.0M+0.0%$15M2.3%
5DFTX Definium Therapeutics Inc286,990+43.5%$14M2.1%
6WK Workiva Inc250,000+0.0%$12M1.9%
7CXM Sprinklr Inc2.2M+0.0%$11M1.8%
8MBX Mbx Biosciences Inc203,543+39.9%$11M1.8%
9ALKT Alkami Technology Inc600,284—$11M1.7%
10CLDX Celldex Therapeutics Inc New290,441−7.0%$11M1.7%
11RLAY Relay Therapeutics Inc570,311+214.1%$11M1.7%
12ARWR Arrowhead Pharmaceuticals In130,484+2.6%$11M1.7%
13PHVS Pharvaris N V295,627+33.4%$10M1.6%
14ALKS Alkermes Plc189,979+18.9%$10M1.6%
15IMVT Immunovant Inc255,934+17.1%$10M1.6%
16SLN Silence Therapeutics Plc764,256+21.3%$8M1.3%
17DYN Dyne Therapeutics Inc356,657+38.2%$8M1.2%
18IONS Ionis Pharmaceuticals Inc97,173+132.7%$8M1.2%
19AGIO Agios Pharmaceuticals Inc205,579+24.7%$8M1.2%
20HRMY Harmony Biosciences Hldgs In201,036+68.5%$7M1.2%
21KRYS Krystal Biotech Inc19,668+0.0%$7M1.2%
22ANNX Annexon Inc1.2M−3.9%$7M1.1%
23CELC Celcuity Inc64,110—$7M1.1%
24WARNER BROS DISCOVERY INC Warner Bros Discovery Inc250,000−72.9%$7M1.0%
25NKTR Nektar Therapeutics86,996−15.6%$6M1.0%
26AMLX Amylyx Pharmaceuticals Inc297,926−6.3%$5M0.8%
27ACAD Acadia Pharmaceuticals Inc167,875+16.1%$4M0.7%
28CUE Cue Biopharma Inc93,819—$3M0.5%
29SNOW Snowflake Inc10,000+0.0%$3M0.4%
30ACRS Aclaris Therapeutics Inc400,000—$2M0.3%
31TECX Tectonic Therapeutic Inc46,516+23.8%$2M0.3%
32GLUE Monte Rosa Therapeutics Inc56,052—$1M0.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.